Medtronic Acquires Diabeter As Part Of Integrated Health Strategy
This article was originally published in The Gray Sheet
Netherlands-based Diabeter is one of Europe’s largest independent diabetes specialist care centers. It will enhance Medtronic’s ongoing strategy to become a complete healthcare “solutions” company.
You may also be interested in...
The company’s leadership team is “determined to transform Medtronic from being a primarily device provider today into the premier global medical technology solutions partner of tomorrow,” CEO Omar Ishrak said.
Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.
Zydus Cadila is to begin testing a three-dose recombinant DNA vaccine candidate in Phase III Indian trials, which might enter late-stage development ahead of Inovio and AnGes. The company promised to provide 100-150 million doses by end of 2021 at the J.P. Morgan Conference, though adherence could be a roadblock.